Request Deal Involvement
Temasek, Ally Bridge Group, and TCG Crossover led a $215 Series B funding round in Arbor Biotechnologies.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Solebury Trout
or
Principals
bidder
TCG CROSSOVER
bidder
GREAT POINT PARTNERS LLC
bidder
ARROWMARK PARTNERS
bidder
SECTION 32 (S32)
bidder
TEMASEK HOLDINGS LIMITED
bidder
ALLY BRIDGE GROUP
bidder
ILLUMINA VENTURES
bidder
LOGOS CAPITAL
target
ARBOR BIOTHECHNOLOGIES
bidder
JANUS HENDERSON INVESTORS
bidder
PIPER HEARTLAND HEALTHCARE CAPITAL
bidder
SURVEYOR CAPITAL
bidder
DEEP TRACK CAPITAL
bidder
ONO VENTURE INVESTMENT
bidder
RIDGEBACK CAPITAL INVESTMENTS
bidder
T. ROWE PRICE GROUP INC
bidder
TAO CAPITAL PARTNERS
bidder
TEKLA CAPITAL MANAGEMENT LLC
bidder
WOODLINE PARTNERS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite